Evidence for a vascular factor in migraine

Annals of Neurology

Volumn 69, Issue 4, 2011, Pages 635-645

  Asghar, Mohammad S ^a   Hansen, Adam E ^a,b   Amin, Faisal M ^a   Van Der Geest, R J ^c   Koning, Patrick Van Der ^c   Larsson, Henrik B W ^a,b   Olesen, Jes ^a   Ashina, Messoud ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; SUMATRIPTAN;

ADULT; ANALGESIA; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD VESSEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; END TIDAL CARBON DIOXIDE TENSION; EXPERIMENTAL DESIGN; FEMALE; HEADACHE; HEART RATE; HUMAN; IMAGE RECONSTRUCTION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MENINGEAL ARTERY; MIDDLE CEREBRAL ARTERY; MIDDLE MENINGEAL ARTERY; MIGRAINE WITHOUT AURA; NEUROIMAGING; NEUROLOGIC DISEASE; PAIN ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; SIDE EFFECT; THREE DIMENSIONAL IMAGING; VASODILATATION;

ADULT; ARTERIES; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MENINGES; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; MIGRAINE WITHOUT AURA; SUMATRIPTAN; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 79955452648     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22292     Document Type: Article

References (41)

1. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68: 343-349. (Pubitemid 46184209)
2. Andlin-Sobocki P, Jönsson B, Wittchen H, Olesen J,. Cost of disorders of the brain in Europe. Eur J Neurol 2005; 12 (suppl 1): 1-27.
3. Isler H, Koehler PJ,. History of the headache. In:, Olesen J, Tfelt-Hansen P, Welch KM, et al. The headaches. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2005: 1-7.
4. Ray BS, Wolff HG,. Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Arch Surg 1940; 41: 813-856.
5. Brennan K, Charles A,. An update on the blood vessel in migraine. Curr Opin Neurol 2010; 23: 266-274.
6. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995; 1: 658-660.
7. Bahra A, Matharu MS, Buchel C, et al. Brainstem activation specific to migraine headache. Lancet 2001; 357: 1016-1017. (Pubitemid 32285399)
8. May A, Goadsby PJ,. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999; 19: 115-127. (Pubitemid 29284258)
9. Sakai Y, Dobson C, Diksic M, et al. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis. Neurology 2008; 70: 431-439.
10. Schoonman G, van der Grond J, Kortmann C, et al. Migraine headache is not associated with cerebral or meningeal vasodilatationâa 3T magnetic resonance angiography study. Brain 2008; 131 (pt 8): 2192-2200.
11. Schoonman GG, Ferrari MD,. Reply to: Migraine headache is not associated with cerebral or meningeal vasodilatationâa 3T magnetic resonance angiography study. Brain 2008; 132: e113.
12. Brain SD, Williams TJ, Tippins JR, et al. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985; 313: 54-56. (Pubitemid 15192304)
13. McCulloch J, Uddman R, Kingman TA, Edvinsson L,. Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A 1986; 83: 5731-5735. (Pubitemid 16001291)
14. Lassen L, Haderslev P, Jacobsen V, et al. CGRP may play a causative role in migraine. Cephalalgia 2002; 22: 54-61. (Pubitemid 34626025)
15. Petersen K, Lassen L, Birk S, et al. BIBNBS$6$7 antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 2005; 77: 202-213. (Pubitemid 40269135)
16. de Koning P, Schaap J, Janssen J, et al. Automated segmentation and analysis of vascular structures in magnetic resonance angiographic images. Magn Reson Med 2003; 50: 1189-1198. (Pubitemid 37494019)
17. Asghar MS, Hansen AE, Kapijimpanga TR, et al. Dilatation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology 2010; 75: 1494-1495.
18. Graham JR, Wolff HG,. Mechanism of migraine headache and action or ergotamine tartrate. Arch Neurol Psychiatry 1938; 39: 737-763.
19. Wahl M, Schilling L, Parsons AA, Kaumann A,. Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res 1994; 637: 204-210. (Pubitemid 24061049)
20. Lauritzen M, Fabricius M,. Real time laser-Doppler perfusion imaging of cortical spreading depression in rat neocortex. Neuroreport 1995; 6: 1271-1273.
21. Woods RP, Iacoboni M, Mazziotta JC,. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994; 331: 1689-1692. (Pubitemid 24373622)
22. Olesen J, Larsen B, Lauritzen M,. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981; 9: 344-352. (Pubitemid 11106551)
23. Lauritzen M, Olesen J,. Regional cerebral blood flow during migraine attacks by xenon-133 inhalation and emission tomography. Brain 1984; 107 (pt 2): 447-461. (Pubitemid 14108830)
24. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001; 98: 4687-4692. (Pubitemid 32295037)
25. Lauritzen M,. Pathophysiology of the migraine aura: the spreading depression theory. Brain 1994; 117: 199-210. (Pubitemid 24103394)
26. Thomsen LL, Iversen HK, Olesen J,. Cerebral blood flow velocities are reduced during attacks of unilateral migraine without aura. Cephalalgia 1995; 15: 109-116.
27. Iversen HK, Nielsen TH, Olesen J, Tfelt-Hansen P,. Arterial responses during migraine headache. Lancet 1990; 336: 837-839. (Pubitemid 20311327)
28. Zwetsloot CP, Caekebeke JF, Ferrari MD,. Lack of asymmetry of middle cerebral artery blood velocity in unilateral migraine. Stroke 1993; 24: 1335-1338. (Pubitemid 23254636)
29. Brain S, Cambridge H,. Calcitonin gene-related peptide: vasoactive effects and potential therapeutic role. Gen Pharmacol 1996; 27: 607-611. (Pubitemid 26233328)
30. Goadsby PJ, Charbit AR, Andreou AP, et al. Neurobiology of migraine. Neuroscience 2009; 161: 327-341.
31. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P,. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 2009; 8: 679-690.
32. Mayberg M, Langer RS, Zervas NT, Moskowitz MA,. Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science 1981; 213: 228-230. (Pubitemid 11060572)
33. Strassman AM, Raymond SA, Burstein R,. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996; 384: 560-564. (Pubitemid 26415932)
34. Burstein R, Jakubowski M,. Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol 2005; 493: 9-14. (Pubitemid 41636179)
35. Humphrey PP, Goadsby PJ,. The mode of action of sumatriptan is vascular? A debate. Cephalalgia 1994; 14: 401-410; discussion 393. (Pubitemid 24381752)
36. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB,. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002; 22: 633-658. (Pubitemid 36609333)
37. Tfelt-Hansen PC,. Does sumatriptan cross the blood-brain barrier in animals and man ? J Headache Pain 2010; 11: 5-12.
38. Moskowitz MA,. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43 (6 suppl 3): S16-S20.
39. Williamson DJ, Hargreaves RJ,. Neurogenic inflammation in the context of migraine. Microsc Res Tech 2001; 53: 167-178. (Pubitemid 32378031)
40. Levy D, Jakubowski M, Burstein R,. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists. Proc Natl Acad Sci U S A 2004; 101: 4274-4279. (Pubitemid 38405919)
41. Olesen J,. The international classification of headache disorders. 2nd edition (ICHD-II). Rev Neurol (Paris) 2005; 161: 689-691.